Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
ARCT
ARCT News & Events
-
Add to Watchlist
Trade ARCT
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
ARCT News
Arcturus to Present mRNA Technologies at J.P. Morgan Healthcare Conference
Jan 08 2026
Businesswire
Arcturus Announces Launch of 12-Week Cystic Fibrosis Study in 2026, Facing Cost Management and KOSTAIVE BLA Delays
Nov 10 2025
SeekingAlpha
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) and Encourages Investors with Substantial Losses to Contact the Firm
Nov 10 2025
PRnewswire
Cathie Wood Reduces Holdings in AMD and Other U.S. Tech Stocks, Increases Investment in Baidu and Biotech Sectors
Oct 25 2025
TipRanks
Molina Healthcare Analyst Adopts Bearish Stance; Check Out the Top 5 Downgrades for Friday
Oct 24 2025
Benzinga
Citi Downgrades Arcturus to Neutral Following mRNA Candidate Data Release
Oct 24 2025
SeekingAlpha
Cathie Wood Makes Major Investments in Alibaba, Baidu, and Arcturus While Reducing Holdings in AMD, SoFi, and Shopify
Oct 24 2025
TipRanks
Investor Notice: Pomerantz Law Firm Probes Allegations for Arcturus Therapeutics Holdings Inc. Investors - ARCT
Oct 24 2025
Globenewswire
Show More News
ARCT Events
12/30 16:10
Arcturus Therapeutics Files $500M Mixed Securities Shelf
Arcturus Therapeutics files $500M mixed securities shelf
Show More Events
ARCT Monitor News
No data
ARCT Earnings Analysis
No Data
People Also Watch
